Methods and compositions for treating abnormal cell growth
US10406158B2 · kind B2 · utility
3Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2018 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | Apr 2, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.